Patents - stay tuned to the technology

Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Carbon double bonded directly to the cyclopentanohydrophenantrene ring system

Subclass of:

552 - Organic compounds -- part of the class 532-570 series

552000000 - ORGANIC COMPOUNDS (CLASS 532, SUBCLASS 1)

552502000 - Cyclopentanohydrophenanthrene ring system containing

Patent class list (only not empty are listed)

Deeper subclasses:

Class / Patent application numberDescriptionNumber of patent applications / Date published
552526000 Carbon double bonded directly to the cyclopentanohydrophenantrene ring system 9
20080234505Exemestane and Its Intermediates and Methods of Making the Same - A method is provided for preparing an aromatase inhibitor of formula (I) wherein each of R09-25-2008
20080275259Process for preparing aromatase inhibitors - A process of making an aromatase inhibitor of formula (I)11-06-2008
20090177001NOVEL PROCESS AND INTERMEDIATES - The present invention relates to a process for the preparation of steroidal 17β-carboxylic thioates. More particularly the present invention relates to a convenient and efficient synthesis of steroidal 17β-carboxylic thioates, such as fluticasone propionate I, using soluble mixed fluorides to introduce fluorine by displacing an appropriate leaving group X in compounds II resulting in selective and controlled fluorination. The present invention also relates to intermediates II and their preparation.07-09-2009
20090275767PROCESS FOR SYNTHESIS OF ANDROSTANE 17-BETA CARBOTHIOIC ACID AND RELATIVE COMPOUNDS THEREOF - A process for synthesis of androstane 17-β carbothioic acid is provided. The process includes mixing an androstane 17-β carboxylic acid and a coupling reagent, and adding an alkanethioic acid to form an androstane 17-β carbothioic acid, wherein the androstane 17-β carbothioic acid has the formula (I):11-05-2009
20110118488PROCESS FOR OBTAINING 6-ALKYLIDENANDROST-1, 4-DIENE-3-ONE - 6-alkylidenandrost-1,4-dien-3-ones of general formula (I), wherein R is H o alkyl; R05-19-2011
20110124894METHOD FOR OBTAINING LONG CHAIN ALIPHATIC ALCOHOLS AND FATTY ACIDS FROM SUGAR CANE MUD AND RELATED WAX ESTERS - Methods are provided for the extraction of wax esters from sugar cane mud, isolation of the wax, saponification of the wax, either after isolation or in an intermediate un-isolated form to provide higher primary aliphatic alcohols (HPAA's) and fatty acids having nutritional and medicinal uses. The solid waste resulting from the process can be disposed of or utilized as a soil substitute following an optional water wash. Additionally, methods are provided for providing modified forms of the sugar cane mud or cachaza having reduced volumes and/or water content that require less storage space and capable of being stored for long periods of time with little or no biological degradation.05-26-2011
20120209016Exemestane and its Intermediates and Methods of Making the Same - A method is provided for preparing an aromatase inhibitor of formula (I)08-16-2012
20120232296ANTISOLVENT SOLIDIFICATION PROCESS - The present invention relates to a antisolvent solidification process wherein a liquid medium comprising at least one organic or inorganic compound which is to be solidified is forced through a membrane into one or more antisolvents, or wherein one or more antisolvents are forced through a membrane into a liquid medium comprising at least one organic or inorganic compound which is to be solidified, yielding a composition comprising solid particles comprising said organic and/or inorganic compound(s).09-13-2012
552530000 The carbon is double bonded directly at the 17-position (e.g., fusidic acids, etc.) 1
552531000 Nitrogen or sulfur containing 1
20140309443NEUROACTIVE 17(20)-Z-VINYLCYANO-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME - The present disclosure is generally directed to neuroactive 17(20)-Z-vinylcyano-substituted compound of Formula (I) and (II), as referenced herein, and pharmaceutically acceptable salts thereof, for use as, for example, an anesthetic, and/or in the treatment of disorders relating to GABA function and activity. The present disclosure is further directed to pharmaceutical compositions comprising such compounds.10-16-2014
Website © 2025 Advameg, Inc.